BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


NonExomics logo



AI Companies (Drug Discovery)

NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – genomics, transcriptomics, proteomics – to predict nonexomic proteins and identify disease-causing targets. NonExomics partners with other biopharma organizations to design biomarker assays, identify biomarker candidates, therapeutic targets and drugs.

Become a Member to view additional information about this company